Therapeutic and diagnostic agents

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S320100, C435S252300, C435S325000, C536S023100, C530S350000

Reexamination Certificate

active

06905842

ABSTRACT:
The present invention relates generally to therapeutic and diagnostic agents. More particularly, the present invention provides therapeutic molecules capable of modulating signal transduction such as but not limited to cytokine-mediated signal transduction. The molecules of the present invention are useful, therefore, in modulating cellular responsiveness to cytokines as well as other mediators of signal transduction such as endogenous or exogenous molecules, antigens, microbes and microbial products, viruses or components thereof, ions, hormones and parasites.

REFERENCES:
patent: 5871960 (1999-02-01), Smith et al.
patent: 6323317 (2001-11-01), Hilton et al.
patent: 0 989 186 (2000-03-01), None
patent: 94/28156 (1994-12-01), None
patent: WO 98/30688 (1998-07-01), None
patent: WO 99/03993 (1999-01-01), None
Schluter et al. Jan., 1996; Molecular Reproductive Development 43(1) 1-6.
Watson et al. Molecular Biology of the Gene, 4th edition. Inside cover, 1987.
Hilton et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 95:114-119, Jan. 1998.
W.S. Alexander et al. (1995) “Point Mutations Within a Dimer Interface Homology Domain of c-Mpl Induce Constitutive Receptor Activity and Tumorigenicity”The Embo Journal 14: 5569-5578.
S.F. Altschul et al. (1990) “Basic Local Alignment Search Tool”J. Mol. Biol. 215: 403-410.
J.F. Bazan (1990) “Haemopoietic Receptors and Helical Cytokines” Immunology Today 11 (10): 350-354.
R.L. Cutler et al. (1993) “Multiple Cytokines Induce the Tyrosine Phosphorylation of Shc and its Association With Grb2 . . . ”The Journal of Biological Chemistry 268(29): 21463-21465.
J.E. Darnell, Jr. et al. (1994) “Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins”Science 264: 1415-1421.
M. David et al. (1995) “Requirement for MAP Kinase (ERK2) Activity in Interferon—alpha and Interferon—beta Stimulated Gene Expression Through STAT Proteins”Science 269: 1721-1723.
M. David et al. (1996) “STAT Activation by Epidermal Growth Factor (EGF) and Amphiregulin”The Journal of Biological Chemistry 271(16): 9185-9188.
A. Dugaiczyk et al. (1983) “Cloning and Sequencing of a Deoxyribonnucleic Acid Copy of Glyceraldehyde-3-phosphate Dehydrogenase Messenger Ribonucleic Acid . . .”Biochemistry 22: 1605-1613.
J.E. Durbin et al. (1996) “Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease”Cell 84: 443-450.
T. Etzold et al. (1996) “SRS: Information Retrieval System for Molecular Biology Data Banks”Method in Enzymoloogy 266: 114-128.
S. Gupta et al. (1996) “The SH2 Domains of Stat1 and Stat2 Mediate Multiple Interactions in the Transduction of IFN—Signals”The EMBO Journal 15(5): 1075-1084.
D.J. Hilton (1994) “An Introduction to Cytokine Receptors”Guidebook to Cytokines and Their ReceptorsOxford, England: Oxford University Press.
D.J. Hilton et al. (1994) “Cloning of a Murine IL-11 Receptor-chain; Requirement for gp130 for High Affinity Binding and Signal Transduction”The EMBO Journal 13(20): 4765-4775.
D.J. Hilton et al. (1996) “Saturation Mutagenesis of the WSXWS Motif of the Erythropoietin Receptor”The Journal of Biological Chemistry 271(9): 4699-4708.
Y. Ichikawa (1969) “Differentiation of a Cell Line of Myeloid Leukemia”J. Cell. Physiol. 74: 223-234.
J.N. Ihle (1995) “Cyotokine Receptor Signalling”Nature 377: 591-594.
M.H. Kaplan et al. (1996) “Stat6 is Reguired for Mediating Respones to IL-4 and for the Development of Th2 Cells”Immunity 4: 313-319.
M.H. Kaplan et al. (1996) “Impaired IL-12 Respones and Enhanced Development of Th2 Cells in Stat4-deficient Mice”Nature 382: 174-179.
D.W. Leaman et al. (1996) “Roles of JAKs in Activation of STATs and Stimulation of c-fos Gene Expression by Epidermal Growth Factor”Mollecular and Cellular Biology 16(1): 369-375.
M.A. Meraz et al. (1996) “Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK-STAT Signaling Pathway”Cell 84: 431-442.
S. Mizushima and S. Nagata (1990) “pEF-BOS, A Powerful Mammalian Expression Vector”Nucleic Acids Research 18(17): 5322.
M. Murakami et al. (1991) “Critical Cytoplasmic Region of the Interleukin 6 Signal Transducer gp130 is Conserved in the Cytokine Receptor Family”Proc. Nat'l. Acad. Sci. USA 88: 11349-11353.
E.J. Neer et al. (1994) “The Ancient Regulatory-protein Family of WD-repeat Proteins”Nature 371: 297-300.
N.A. Nicola et al. (1996) “Molecular Cloning of Two Novel Transmembrane Ligands for Eph-related Kinases (LERKS) That Are Related to LERK-2”Growth Factors 13: 141-149.
U. Novak et al. (1995) “Colony-stimulating Factor 1-Induced STAT1 and STAT3 Activation Is Accompanied by Phosphorylation of Tyk2 in Macrophages and Tyk2 and JAK1 in Fibroblasts”Blood 86(8): 2948-2956.
W.R. Pearson et al. (1988) “Improved Tools for Biological Sequence Comparison”Proc. Nat'l Acad. Sci. USA 85: 2444-2448.
W.R. Pearson (1990) “Rapid and Sensitive Sequence Comparison With FASTP and FASTA”Methods in Enzymology 183: 63-99.
J.R. Rayner and T.J. Gonda (1994) “A Simple and Efficient Procedure for Generating Stable Expression Libraries by cDNA in a Retroviral Vector”Molecular and Cellular Biology 14(2): 880-887.
N. Sato et al. (1993) “Signal Transduction by the High-affinity GM-CSF Receptor: Two Distinct Cytoplasmic Regions of the Common B-Subunit Responsible for Different Signaling”The EMBO Journal 12(11): 4181-4189.
K. Shimoda et al. (1996) “Lack of IL-4-induced Th2 Response and IgE Class Switching in Mice With Disrupted Stat6 Gene”Nature 380: 630-633.
K. Shual et al. (1993) “Polypeptide Signalling to the Nucleus Through Tyrosine Phosphorylation of Jak and Stat Proteins”Nature 366: 580-583.
S.R. Sprang et al. (1993) “Cytokine Structure Taxonomy and Mechanisms for Receptor Engagement”Current Opinion in Structural Biology 3: 815-827.
K. Takeda et al. (1996) “Essential Role of STAT6 in IL-4 Signalling”Nature 380: 627-630.
W.E. Thierfelder et al. (1996) “Requirement for Stat4 in Interleukin-12-mediated Responses of Natural Killer and T-Cells”Nature 382: 171-174.
H. Wakao et al. (1994) “Mammary Gland Factor (MGF) Is a Novel Member of the Cytokine Regulated Transcription Factor Gene Family and Confers the Prolactin Response”The EMBO Journal 13(9): 2182-2191.
Z. Wen et al. (1995) “Maximal Activation of Transcription by Stat1 and Stat3 Requires Both Tyrosine and Serine Phosphorylation”Cell 82: 241-250.
Y. Taolin et al. (1993) “Hematopoietic Cells Phosphatase Associates With the Interleukin-3 (IL-3) Receptor B-Chain and Down-regulates Il-3-Induced Tyrosine Phosphorylation and Mitogenesis”Molecular and Cellular Biology 13(12): 7577-7586.
A. Yoshimura et al. (1995) “A Novel Cytokine-Inducible Gene CIS Encodes An SH2-containing Protein That Binds to Tyrosine-phosphorylated Interleukin 3 and Erythropoietin Receptors”The EMBO Journal 14(12): 2816-2826.
Accession No. U72673, ID: MMU72673 (1997), XP-002172403 (Abstract).
Fu, X. et al., “E2a-Pbx1 Induces Aberrant Expession of Tissue-Specific and Developmentally Regulated Genes When Expressed in NIH 3T3 Fibroblasts”,Molecular and Cellular Biology 17(3):1503-1512 (1997), XP-002172402.
Starr, R et al., “A Family of Cytokine-Inducible Inhibitors of Signalling”,Nature 387:917-921 (1997), XP-002085491.
Endo, T.A. et al., “A New Protein Containing an SH2 Domain that Inhibits JAK Kinases”,Nature 387:927-924 (1997), XP-002085492.
Naka, T. et al., “Structure and Function of a New STAT-Inducted STAT Inhibitor”,

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic and diagnostic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic and diagnostic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3476544

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.